JMTC Capital logo

JMTC Capital

Asia, Tokyo, Japan, Tokyo

Description

JMTC Capital is a material manufacturers to support the material development of R & D ventures.

Investor Profile

JMTC Capital has backed more than 5 startups, with 3 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed, Debt Financing, Series C rounds (top funding stages).
  • Majority of deals are located in Japan, United States.
  • Strong thematic focus on Medical Device, Robotics, Biotechnology.

Stage Focus

  • Seed (40%)
  • Debt Financing (20%)
  • Series C (20%)
  • Series B (20%)

Country Focus

  • Japan (80%)
  • United States (20%)

Industry Focus

  • Medical Device
  • Robotics
  • Biotechnology
  • Environmental Consulting
  • Intellectual Property
  • Renewable Energy
  • Automotive
  • Internet Of Things
  • Mobile
  • Drones
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does JMTC Capital frequently co-invest with?

Dai-ichi Life
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
Daiwa Securities Group
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
Ateam
Asia, Aichi, Japan, Nagoya
Co-Investments: 1
Shizuoka Bank
Asia, Shizuoka, Japan, Shizuoka-shi
Co-Investments: 1
Japan Post Capital
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
15th Rock
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
Shoko Chukin Bank
North America, New York, United States, New York
Co-Investments: 1
Okasan Capital Partners
Asia, Hokkaido, Japan, Chuo
Co-Investments: 1
Juroku Lease
Asia, Gifu, Japan, Gifu-shi
Co-Investments: 1
Ogaki Kyoritsu Bank
Asia, Gifu, Japan, Ogaki
Co-Investments: 1

What are some of recent deals done by JMTC Capital?

KAICO

Nishiku, Fukuoka, Japan

KAICO is a biotechnology company that provides hard-expressing proteins to develop drugs with a silkworm-baculovirus expression system.

Alternative MedicineBiotechnologyPharmaceuticalProduct Research
Series BApr 15, 2025
Amount Raised: $3,765,766
BioPhenoMA

Tokyo, Tokyo, Japan

BioPhenoMA develops an AI-powered platform for detecting ultra-trace proteins that helps accelerate new drug discovery phases.

Artificial Intelligence (AI)B2BBiotechnologyLife ScienceMedicalMedical Device
SeedNov 7, 2024
Amount Raised: $1,240,390
Spiral

Tokyo, Tokyo, Japan

Spiral develops autonomous drone flight systems capable of operating in non-GPS environments.

DronesManufacturingRobotics
SeedAug 26, 2024
Amount Raised: $2,075,945
Photo electron Soul

Nagoya, Aichi, Japan

Photo electron Soul is to innovate the world of "seeing" and "creating" through the development of photocathode electron beam technology.

Environmental ConsultingIntellectual PropertyRenewable Energy
Debt FinancingJul 17, 2020
Amount Raised: $5,794,123
WHILL

San Carlos, California, United States

WHILL designs and creates personal mobility products for indoor and outdoor applications.

AutomotiveInternet of ThingsMedical DeviceMobileRobotics
Series CSep 17, 2018
Amount Raised: $44,765,763